{"id":"W6921424922","doi":"10.7488/era/4945","title":"Treatment targets, real-world outcomes and optimisation of biologic therapies for the treatment of inflammatory bowel disease","year":2024,"lang":"en","type":"other","venue":"ERA","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Vedolizumab; Biosimilar; Infliximab; Adalimumab; Inflammatory bowel disease; Calprotectin; Therapeutic drug monitoring; Ulcerative colitis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01895049,0.0005478206,0.001463785,0.0008682631,0.0003065019,0.003723436,0.0006482132,0.001246582,0.004865662],"category_scores_gemma":[0.03586245,0.0001856327,0.0008599116,0.0009430598,0.0009795551,0.002362511,0.001515853,0.002164672,0.000891049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00291408,"about_ca_system_score_gemma":0.002049806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006225739,"about_ca_topic_score_gemma":0.0006352717,"domain_scores_codex":[0.9845729,0.0104491,0.001283128,0.0006744973,0.00265657,0.0003637988],"domain_scores_gemma":[0.9761856,0.01330822,0.007076568,0.0004280466,0.002108481,0.0008930204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006996533,0.0007714746,0.04570664,0.01091331,0.001690286,0.0002218334,0.0006565622,0.02639576,0.002268612,0.03935789,0.02534323,0.8396779],"study_design_scores_gemma":[0.002985485,0.01894291,0.2222075,0.02830484,0.006053448,0.003367834,0.001986693,0.06058192,0.008279198,0.2088609,0.4379539,0.0004754291],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1356043,0.6837731,0.04080638,0.08749554,0.001814753,0.0005805688,0.001916577,0.0003254234,0.04768333],"genre_scores_gemma":[0.8782416,0.08572389,0.02243121,0.007531516,0.002091427,0.0008364293,0.0007987817,0.00009733779,0.002247853],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01895049,"threshold_uncertainty_score":0.100221,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02551247595547908,"score_gpt":0.2981720574216498,"score_spread":0.2726595814661707,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}